Replimune Group, Inc. (REPL)
8.47
-0.77
(-8.33%)
USD |
NASDAQ |
Jun 10, 16:00
8.555
+0.08
(+1.00%)
Pre-Market: 08:22
Replimune Group 1 Year Total Returns (Daily) : -16.39% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -16.39% |
| June 09, 2026 | -9.23% |
| June 08, 2026 | -13.58% |
| June 05, 2026 | -2.87% |
| June 04, 2026 | 1.86% |
| June 03, 2026 | 3.63% |
| June 02, 2026 | -7.31% |
| June 01, 2026 | 0.22% |
| May 29, 2026 | -7.26% |
| May 28, 2026 | -44.48% |
| May 27, 2026 | -44.18% |
| May 26, 2026 | -44.91% |
| May 22, 2026 | -43.95% |
| May 21, 2026 | -38.30% |
| May 20, 2026 | -43.85% |
| May 19, 2026 | -42.68% |
| May 18, 2026 | -36.18% |
| May 15, 2026 | -27.80% |
| May 14, 2026 | -29.67% |
| May 13, 2026 | -28.48% |
| May 12, 2026 | -47.96% |
| May 11, 2026 | -51.49% |
| May 08, 2026 | -47.62% |
| May 07, 2026 | -53.35% |
| May 06, 2026 | -54.13% |
| Date | Value |
|---|---|
| May 05, 2026 | -71.33% |
| May 04, 2026 | -69.73% |
| May 01, 2026 | -74.07% |
| April 30, 2026 | -73.72% |
| April 29, 2026 | -74.65% |
| April 28, 2026 | -72.28% |
| April 27, 2026 | -70.39% |
| April 24, 2026 | -73.29% |
| April 23, 2026 | -67.72% |
| April 22, 2026 | -73.94% |
| April 21, 2026 | -78.78% |
| April 20, 2026 | -74.11% |
| April 17, 2026 | -72.86% |
| April 16, 2026 | -71.30% |
| April 15, 2026 | -70.43% |
| April 14, 2026 | -74.03% |
| April 13, 2026 | -76.87% |
| April 10, 2026 | -31.21% |
| April 09, 2026 | -19.15% |
| April 08, 2026 | -17.58% |
| April 07, 2026 | 4.14% |
| April 06, 2026 | 14.48% |
| April 02, 2026 | -2.44% |
| April 01, 2026 | -9.40% |
| March 31, 2026 | -21.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Revolution Medicines, Inc. | 243.5% |
| Oncolytics Biotech, Inc. | 87.38% |
| Rocket Pharmaceuticals, Inc. | -17.72% |
| Cogent Biosciences, Inc. | 322.9% |
| Lantern Pharma, Inc. | 15.13% |